Lymphoid Enhancer Binding Factor 1 (LEF1) as a Biomarker for Wnt/Beta-Catenin Pathway Activation in the Biological Progression of Phyllodes Tumors

被引：0
|
作者：
Chen, Po-Han [1 ]
Bossuyt, Veerle [2 ]
Reisenbichler, Emily [1 ]
机构：
[1] Yale Univ, New Haven, CT USA
[2] Massachusetts Gen Hosp, Woodbridge, CT USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
123
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Lymphoid Enhancer Binding Factor 1 (LEF1) as a Biomarker for Wnt/Beta-Catenin Pathway Activation in the Biological Progression of Phyllodes Tumors
    Chen, Po-Han
    Bossuyt, Veerle
    Reisenbichler, Emily
    MODERN PATHOLOGY, 2019, 32
  • [2] Lymphoid enhancer-binding factor 1 (LEF1) immunostaining as a surrogate for β-catenin (CTNNB1) mutations
    Hewer, Ekkehard
    Fischer, Pascal David
    Vassella, Erik
    Knabben, Laura
    Imboden, Sara
    Mueller, Michael D.
    Rau, Tilman T.
    Dettmer, Matthias S.
    JOURNAL OF CLINICAL PATHOLOGY, 2024,
  • [3] LYMPHOID ENHANCER-BINDING FACTOR 1 (LEF1): AN IMMUNOHISTOCHEMICAL PREDICTIVE MARKER FOR WNT-ACTIVATED MEDULLOBLASTOMA
    Ranade, Manali
    Naik, Khushi
    Bapat, Prachi
    Gurav, Mamta
    Shetty, Omshree
    Shah, Aekta
    Sahay, Ayushi
    Prasad, Maya
    Singh, Vikash
    Shetty, Prakash
    Moiyadi, Aliasgar
    Dasgupta, Archya
    Chatterjee, Abhishek
    Chinnaswamy, Girish
    Gupta, Tejpal
    Epari, Sridhar
    NEURO-ONCOLOGY, 2024, 26
  • [4] Diagnostic utility of LEF1 and β-catenin in WNT pathway tumors with CTNNB1 mutation
    Li, Can
    Dong, Lingdan
    Zhu, Li
    Guan, Wenbin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2025, 23 (01)
  • [5] Submucosal gland development in the airway is controlled by Lymphoid Enhancer Binding Factor 1 (LEF1)
    Duan, DS
    Yue, YP
    Zhou, WH
    Lebed, B
    Ritchie, TC
    Grosschedl, R
    Engelhardt, JF
    DEVELOPMENT, 1999, 126 (20): : 4441 - 4453
  • [6] Wnt signaling regulates lymphoid enhancer factor (Lef-1) isoform expression through functional interactions between PITX2, beta-catenin and Lef-1
    Amendt, Brad A.
    Liu, Xiaoming
    Amen, Melanie
    Engelhardt, John F.
    FASEB JOURNAL, 2007, 21 (05): : A656 - A656
  • [7] ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway
    Ding, Yang
    Ning, Yumei
    Kang, Hui
    Yuan, Yuan
    Lin, Kun
    Wang, Chun
    Yi, Yun
    He, Jianghua
    Li, Lurao
    He, Xingxing
    Chang, Ying
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [8] ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway
    Yang Ding
    Yumei Ning
    Hui Kang
    Yuan Yuan
    Kun Lin
    Chun Wang
    Yun Yi
    Jianghua He
    Lurao Li
    Xingxing He
    Ying Chang
    Experimental Hematology & Oncology, 13
  • [9] Lymphoid Enhancer Binding Factor-1 (LEF1) Expression As a Prognostic Factor In Adult Acute Promyelocytic Leukemia
    Albano, Francesco
    Anelli, Luisa
    Zagaria, Antonella
    Minervini, Crescenzio Francesco
    Orsini, Paola
    Impera, Luciana
    Casieri, Paola
    Minervini, Angela
    Tota, Giuseppina
    Pastore, Domenico
    Carluccio, Paola
    Cellamare, Angelo
    Brunetti, Claudia
    Coccaro, Nicoletta
    Specchia, Giorgina
    BLOOD, 2013, 122 (21)
  • [10] Overexpression of Lymphoid Enhancer-Binding Factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas
    Singhi, Aatur D.
    Lilo, Mhammed
    Hruban, Ralph H.
    Cressman, Kristi L.
    Fuhrer, Kimberly
    Seethala, Raja R.
    MODERN PATHOLOGY, 2014, 27 (10) : 1355 - 1363
12345